Saturday 17 October 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024. In the quarter to June 2026, revenue grew 59.3%, EPS grew 184.6%, free cash flow grew 228.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

28.82 0.28 −0.96%

Follow ARQT

Alert me

Market cap: $3.7B
P/E: 131×
Fwd P/E: 196×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	4	6	7
ROE Full definition →		(28.17%)	(9.30%)	(1.43%)	15.86%
ROA Full definition →		(10.97%)	(4.13%)	(0.59%)	6.78%
ROIC Full definition →		(31.79%)	(9.91%)	2.69%	23.62%
Return on Tangible Assets Full definition →		(17.68%)	(5.71%)	(0.86%)	9.25%
Average Days of Receivables Full definition →		132.16	141.92	126.79	122.06
Free Cash Flow per Share Full definition →		(0.38)	(0.17)	0.21	0.30
Free Cash Flow Full definition →		(48.24)	(21.31)	26.99	39.07
Capital Expenditures Full definition →		(15.69)	(15.69)	—	(0.24)
Other line items
Cash ROIC Full definition →		(10.53%)	(4.10%)	5.16%	6.87%
Accounts Receivable Turnover Full definition →		3.63	3.43	3.62	3.54
Accounts Payable Turnover Full definition →		2.54	2.74	1.76	3.79
Inventory Turnover Full definition →		1.75	1.98	1.39	1.49
Average Days of Payables Full definition →		66.28	124.61	177.38	58.65
Days of Inventory on Hand Full definition →		256.42	225.14	362.50	345.31
Tax Rate Full definition →		0.02	0.08	0.71	(0.03)
Research and Development Expense of Revenue Full definition →		22.36%	20.49%	21.69%	19.62%
Selling, General and Administrative Expense of Revenue Full definition →		79.64%	73.01%	68.48%	64.14%
Share Based Compensation of Revenue Full definition →		12.49%	10.73%	9.93%	9.39%
Interest Coverage Full definition →		(2.61)	(1.01)	0.24	2.47
Operating CF/Net income Full definition →		0.73	0.35	(11.36)	1.38
Depreciation/Fixed assets Full definition →		1.00	2.47	0.80	1.50
Capex/Depreciation Full definition →		(12.90)	(6.10)	0.00	(0.18)
Revenue per Share Full definition →		2.49	2.96	3.21	3.55
Operating CF per Share Full definition →		(0.26)	(0.04)	0.21	0.30
Capex per Share Full definition →		(0.12)	(0.12)	0.00	0.00
Capex to Sales Full definition →		0.05	0.04	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly